scispace - formally typeset
L

Luc Van Gaal

Researcher at University of Antwerp

Publications -  257
Citations -  23390

Luc Van Gaal is an academic researcher from University of Antwerp. The author has contributed to research in topics: Type 2 diabetes & Population. The author has an hindex of 64, co-authored 247 publications receiving 19698 citations. Previous affiliations of Luc Van Gaal include Turku University Hospital & Luton and Dunstable Hospital.

Papers
More filters
Journal ArticleDOI

Mechanisms linking obesity with cardiovascular disease

TL;DR: The underlying mechanisms as well as the ways in which smoking and dyslipidaemia increase, and physical activity attenuates, the adverse effects of obesity on cardiovascular health are beginning to be understood.
Journal ArticleDOI

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

TL;DR: CB1 blockade with rimonabant 20 mg, combined with a hypocaloric diet over 1 year, promoted significant decrease of bodyweight and waist circumference, and improvement in cardiovascular risk factors.
Journal ArticleDOI

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, +798 more
- 27 Oct 2018 - 
TL;DR: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events, and evidence-based glucagon-like peptide 1 receptor agonists should be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events.